PhaseBio Pharmaceuticals, Inc.
Metalloenzyme inhibitor compounds
Last updated:
Abstract:
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
Status:
Grant
Type:
Utility
Filling date:
7 Sep 2018
Issue date:
22 Jun 2021